Precipio's pathology division exceeds breakeven revenues in august, four months ahead of plan

New haven, conn., sept. 13, 2023 (globe newswire) -- specialty cancer diagnostics company precipio, inc. (nasdaq: prpo) , announces its pathology division has in august exceeded the monthly breakeven revenue goal which, if continued, causes this division to contribute cash to the company's operations.
PRPO Ratings Summary
PRPO Quant Ranking